Innovative Drug Delivery Systems: From Nanotechnology to Smart Devices
A special issue of Pharmaceutics (ISSN 1999-4923). This special issue belongs to the section "Pharmaceutical Technology, Manufacturing and Devices".
Deadline for manuscript submissions: 31 May 2025 | Viewed by 600
Special Issue Editors
Interests: targetted drug delivery; nanomedicine; formulations; biologics; ingestible devices
Interests: biomaterials; biofabrication; neural engineering; bone regeneration; drug delivery
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
The effective delivery of poorly soluble therapeutic molecules, as well as modern pharmaceutical macromolecules, is a critical challenge. Traditional drug delivery systems often face significant obstacles for these types of drugs, such as inadequate dissolution, rapid degradation, and limited absorption, leading to poor bioavailability. These limitations can reduce the efficacy of drugs and require higher doses that may lead to adverse side effects. The need for more efficient, targeted, and patient-friendly drug delivery approaches has driven research toward innovative technologies that are able to overcome these challenges. Recent advances in drug delivery systems have expanded beyond conventional particles and encapsulation methods. The development of smart nanoformulations, advanced materials, and ingestible devices has opened up new opportunities to enhance drug stability, optimize drug release profiles, and improve bioavailability.
This Special Issue aims to highlight the latest advances in this field, showcasing studies on novel nanoformulations, multifunctional platforms, and smart ingestible devices with controlled drug release profiles. I invite contributions that explore both established and emerging technologies, address key challenges, and provide experimental or theoretical insights into advanced drug delivery systems.
- Novel Drug Formulations: the development of advanced formulations to enhance drug stability, solubility, and targeted delivery.
- Smart and Responsive Systems: drug delivery platforms that respond to physiological stimuli (e.g., pH, enzymes, and temperature) for controlled and site-specific release.
- Drug Release Mechanisms: studies on controlled release kinetics, sustained drug delivery, and the optimization of release profiles.
- Micro and Nanotechnology: the use of micro and nano devices to improve drug encapsulation, protect against degradation, and enhance membrane permeability.
- Ingestible Devices: design and characterization of ingestible drug delivery systems, including capsules and microdevices with control capabilities.
- Fabrication Techniques: advances in microfabrication, 3D printing, and other fabrication technologies for creating complex drug delivery devices.
- In Vitro and In Vivo Studies: experimental evaluation of novel drug delivery systems, including their pharmacokinetics, pharmacodynamics, and biocompatibility.
I look forward to receiving your contributions.
Dr. Mahdi Ghavami
Dr. Zhongyang Zhang
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- smart nanoparticles
- innovative drug delivery
- ingestible devices
- targeted delivery systems
- controlled release
- microfabrication techniques
- nano and microtechnology
- biocompatible materials
- bioavailability
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue policies can be found here.
